MicroRNA and colorectal cancer - PubMed
Review
MicroRNA and colorectal cancer
Linda Yang et al. World J Surg. 2009 Apr.
Abstract
MicroRNAs are small 19 to 22 nucleotide sequences of RNA that participate in the regulation of cell differentiation, cell cycle progression, and apoptosis. MicroRNAs act much like small interfering RNA, annealing with RISC, to cleave messenger RNA, and microRNAs exert translational inhibition that is incompletely understood. They are important factors in tumorigenesis and have been the subject of research in many types of cancers, including colon cancer. MicroRNAs may be abnormally down-regulated or up-regulated in colon-cancer tissue. Artificial dysregulation of certain microRNAs will trigger tumorigenesis or apoptosis depending on which microRNA is manipulated. Although the natural mechanisms for the dysregulation of microRNAs is still largely unknown, one theory tested in colon cancers proposes that DNA hypermethylation leads to down-regulation of certain microRNAs. Specific microRNA expression patterns help characterize specific cancers and may be used as a prognostication factor and in following patient response to 5-fluorouracil chemotherapy. This article reviews the existing literature pertaining to the study of microRNA in colorectal cancer.
Similar articles
-
Shang J, Yang F, Wang Y, Wang Y, Xue G, Mei Q, Wang F, Sun S. Shang J, et al. J Cell Biochem. 2014 Apr;115(4):772-84. doi: 10.1002/jcb.24721. J Cell Biochem. 2014. PMID: 24249161
-
Zhang Y, Talmon G, Wang J. Zhang Y, et al. Cell Death Dis. 2015 Aug 6;6(8):e1845. doi: 10.1038/cddis.2015.200. Cell Death Dis. 2015. PMID: 26247730 Free PMC article.
-
Li PL, Zhang X, Wang LL, Du LT, Yang YM, Li J, Wang CX. Li PL, et al. Carcinogenesis. 2015 Dec;36(12):1484-93. doi: 10.1093/carcin/bgv145. Epub 2015 Oct 6. Carcinogenesis. 2015. PMID: 26442524
-
MicroRNAs and drug resistance in colorectal cancer with special focus on 5-fluorouracil.
Pouya FD, Gazouli M, Rasmi Y, Lampropoulou DI, Nemati M. Pouya FD, et al. Mol Biol Rep. 2022 Jun;49(6):5165-5178. doi: 10.1007/s11033-022-07227-1. Epub 2022 Feb 25. Mol Biol Rep. 2022. PMID: 35212928 Review.
-
MicroRNA Methylation in Colorectal Cancer.
Kaur S, Lotsari-Salomaa JE, Seppänen-Kaijansinkko R, Peltomäki P. Kaur S, et al. Adv Exp Med Biol. 2016;937:109-22. doi: 10.1007/978-3-319-42059-2_6. Adv Exp Med Biol. 2016. PMID: 27573897 Review.
Cited by
-
Suyundikov A, Stevens JR, Corcoran C, Herrick J, Wolff RK, Slattery ML. Suyundikov A, et al. PLoS One. 2015 Apr 7;10(4):e0119876. doi: 10.1371/journal.pone.0119876. eCollection 2015. PLoS One. 2015. PMID: 25849489 Free PMC article.
-
Hu M, Xia M, Chen X, Lin Z, Xu Y, Ma Y, Su L. Hu M, et al. Dig Dis Sci. 2010 Aug;55(8):2365-72. doi: 10.1007/s10620-009-1008-9. Epub 2009 Oct 15. Dig Dis Sci. 2010. PMID: 19830559
-
MicroRNA Biomarkers as Promising Tools for Early Colorectal Cancer Screening-A Comprehensive Review.
Santos DAR, Gaiteiro C, Santos M, Santos L, Dinis-Ribeiro M, Lima L. Santos DAR, et al. Int J Mol Sci. 2023 Jul 3;24(13):11023. doi: 10.3390/ijms241311023. Int J Mol Sci. 2023. PMID: 37446201 Free PMC article. Review.
-
An evaluation and replication of miRNAs with disease stage and colorectal cancer-specific mortality.
Slattery ML, Herrick JS, Mullany LE, Valeri N, Stevens J, Caan BJ, Samowitz W, Wolff RK. Slattery ML, et al. Int J Cancer. 2015 Jul 15;137(2):428-38. doi: 10.1002/ijc.29384. Epub 2014 Dec 16. Int J Cancer. 2015. PMID: 25484364 Free PMC article.
-
MetastamiRs: non-coding MicroRNAs driving cancer invasion and metastasis.
Lopez-Camarillo C, Marchat LA, Arechaga-Ocampo E, Perez-Plasencia C, Moral-Hernandez OD, Castaneda-Ortiz EJ, Rodriguez-Cuevas S. Lopez-Camarillo C, et al. Int J Mol Sci. 2012;13(2):1347-1379. doi: 10.3390/ijms13021347. Epub 2012 Jan 27. Int J Mol Sci. 2012. PMID: 22408395 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical